Numan (Series A)
Funding Details
Awarder
Inbox
Date Award
July 21, 2025
Vertical
Healthtech
Funding Amount
$57,000,000
Company Info
Founding Year
2018
Traction
Numan's revenue more than doubled year-on-year to $90m in 2024, with weight loss treatment making up the majority of the startup’s revenue. The company is predicting close to $200m in revenue in 2025.
Revenue Amount
$90,000,000
Founders
Sokratis Papafloratos
Market
Weight loss treatment
Location
United Kingdom
Coinvestors
Big Pi Ventures, HSBC Innovation Banking
Company Description

Numan is a digital health provider that began prescribing GLP-1s along with an obesity management programme in September 2023. The company has pivoted from focusing on men's health to weight loss treatment due to a surge in demand for weight loss drugs.

Links